Literature DB >> 33072488

Evolution of Care of Orbital Tumors with Radiation Therapy.

Myrsini Ioakeim-Ioannidou1, Shannon M MacDonald1.   

Abstract

Orbital tumors are rare lesions comprising 0.1% of all tumors and less than 20% of all ocular diseases. These lesions in children and adults differ significantly in their incidence, tumor type, and treatment management. Although surgery and systemic therapies are commonly used in the management of these diseases, radiation therapy has become a widely used treatment for both benign and malignant tumors of the orbit. Radiotherapy is used as a definitive treatment to provide local control while avoiding morbidity associated with surgery for some tumors while it is used as an adjuvant treatment following surgical resection for others. For many tumors, radiation provides excellent tumor control with preservation of visual function. This article is dedicated for presenting the most common applications of orbital radiotherapy. A brief overview of the commonly available radiation therapy modalities is given. Dose constraint goals are reviewed and acute and long-term side effects are discussed. Orbital tumors covered in this article include optic glioma, ocular melanoma, retinoblastoma, orbital rhabdomyosarcoma, orbital lymphoma, and lacrimal gland tumors. Background information, indications for radiotherapy, and goals of treatment for each case example are described. Thieme. All rights reserved.

Entities:  

Keywords:  IMRT; carbon-ion; carcinoma; glioma; lymphoma; melanoma; proton therapy; radiation; retinoblastoma; sarcoma

Year:  2020        PMID: 33072488      PMCID: PMC7561458          DOI: 10.1055/s-0040-1713894

Source DB:  PubMed          Journal:  J Neurol Surg B Skull Base        ISSN: 2193-634X


  104 in total

1.  Proton radiotherapy for pediatric central nervous system germ cell tumors: early clinical outcomes.

Authors:  Shannon M MacDonald; Alexei Trofimov; Sairos Safai; Judith Adams; Barbara Fullerton; David Ebb; Nancy J Tarbell; Torunn I Yock
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-05-06       Impact factor: 7.038

2.  Second nonocular tumors among survivors of retinoblastoma treated with contemporary photon and proton radiotherapy.

Authors:  Roshan V Sethi; Helen A Shih; Beow Y Yeap; Kent W Mouw; Robert Petersen; David Y Kim; John E Munzenrider; Eric Grabowski; Carlos Rodriguez-Galindo; Torunn I Yock; Nancy J Tarbell; Karen J Marcus; Shizuo Mukai; Shannon M MacDonald
Journal:  Cancer       Date:  2013-10-02       Impact factor: 6.860

3.  Phase II study of weekly vinblastine in recurrent or refractory pediatric low-grade glioma.

Authors:  Eric Bouffet; Regina Jakacki; Stewart Goldman; Darren Hargrave; Cynthia Hawkins; Manohar Shroff; Juliette Hukin; Ute Bartels; Nicholas Foreman; Stewart Kellie; Joanne Hilden; Michael Etzl; Beverly Wilson; Derek Stephens; Uri Tabori; Sylvain Baruchel
Journal:  J Clin Oncol       Date:  2012-03-05       Impact factor: 44.544

Review 4.  The collaborative ocular melanoma study.

Authors:  Arun D Singh; Tero Kivelä
Journal:  Ophthalmol Clin North Am       Date:  2005-03

5.  The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: V. Twelve-year mortality rates and prognostic factors: COMS report No. 28.

Authors: 
Journal:  Arch Ophthalmol       Date:  2006-12

6.  Association of ocular and oculodermal melanocytosis with the rate of uveal melanoma metastasis: analysis of 7872 consecutive eyes.

Authors:  Carol L Shields; Swathi Kaliki; Michael Livesey; Brianna Walker; Robert Garoon; Marissa Bucci; Eric Feinstein; Aline Pesch; Cristina Gonzalez; Sara E Lally; Arman Mashayekhi; Jerry A Shields
Journal:  JAMA Ophthalmol       Date:  2013-08       Impact factor: 7.389

7.  Outcomes in patients with adenoid cystic carcinoma of the lacrimal gland.

Authors:  Bita Esmaeli; M Amir Ahmadi; Adel Youssef; Roxana Diba; Malena Amato; Jeffrey N Myers; Merrill Kies; Adel El-Naggar
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2004-01       Impact factor: 1.746

8.  Eye-Preserving Surgery Followed by Adjuvant Radiotherapy for Lacrimal Gland Carcinoma: Outcomes in 37 Patients.

Authors:  Kyung In Woo; Oded Sagiv; Jisang Han; Steven J Frank; Yoon-Duck Kim; Bita Esmaeli
Journal:  Ophthalmic Plast Reconstr Surg       Date:  2018 Nov/Dec       Impact factor: 1.746

9.  The Third Intergroup Rhabdomyosarcoma Study.

Authors:  W Crist; E A Gehan; A H Ragab; P S Dickman; S S Donaldson; C Fryer; D Hammond; D M Hays; J Herrmann; R Heyn
Journal:  J Clin Oncol       Date:  1995-03       Impact factor: 44.544

10.  Prognostic factors and results of radiation therapy in optic pathway tumors.

Authors:  C A Regueiro; M V Ruiz; I Millán; A de la Torre; J Romero; G Aragón
Journal:  Tumori       Date:  1996 Jul-Aug
View more
  4 in total

1.  Extrapulmonary Small Cell Carcinoma Presenting as an Orbital Mass: A Case Report.

Authors:  Anna-Lena Meinhardt; Aditya Uppuluri; Elina Shkolnik; Victor T Chang
Journal:  Cureus       Date:  2022-06-16

2.  Mucosa-associated lymphoid tissue of nasopharynx: A case report and literature review.

Authors:  Tianci Tang; Xiaochen Ni; Xinmao Song
Journal:  Radiol Case Rep       Date:  2022-06-17

Review 3.  Orbital Metastases: A Systematic Review of Clinical Characteristics, Management Strategies, and Treatment Outcomes.

Authors:  Paolo Palmisciano; Gianluca Ferini; Christian Ogasawara; Waseem Wahood; Othman Bin Alamer; Aditya D Gupta; Gianluca Scalia; Alexandra M G Larsen; Kenny Yu; Giuseppe E Umana; Aaron A Cohen-Gadol; Tarek Y El Ahmadieh; Ali S Haider
Journal:  Cancers (Basel)       Date:  2021-12-24       Impact factor: 6.639

4.  Ultra-low dose radiotherapy in the management of low-grade orbital lymphomas.

Authors:  Bárbara de Castro; Rita Pinho Peixeiro; José Mário Mariz; Ângelo Oliveira
Journal:  Rep Pract Oncol Radiother       Date:  2022-07-29
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.